Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Hydrogel microneedles with special nanoparticles and growth factor improve hair growth better than minoxidil for hair loss treatment.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Targeting the PGD2-DP2 pathway may help treat hair loss.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

GLP-1 agonists may increase the risk of hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.